Literature DB >> 18983986

Crosstalk between the AHR signaling pathway and circadian rhythm.

Shigeki Shimba1, Yuichi Watabe.   

Abstract

In this chapter, we review the crosstalk between the AHR signaling pathway and molecular clock system in mammals. In mammals, circadian rhythm is observed in most physiological functions including behavior, metabolism, cell growth, and immune responses. Circadian rhythm is regulated by a transcriptional feedback loop, and the transcription factor called "Brain Muscle ARNT-like protein 1 (BMAL1)" is a master regulator of this system. Because of its structural similarity to ARNT, a partner of AHR, BMAL1 is also referred as ARNT3. This structural feature of BMAL1 suggests that the activation of the AHR signaling pathway may influence the regulation of circadian rhythm. Several studies have shown that the expression levels of AHR display diurnal variation in many tissues. This circadian variation of AHR means that the pharmacological effects of AHR agonists vary according to the time of administration. AHR agonist administration results in a disruption of circadian rhythm with regard to behavior, immune cell proliferation, etc. As such, understanding the crosstalk between the AHR signaling and circadian rhythm may provide a new insight into TCDD actions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18983986     DOI: 10.1016/j.bcp.2008.09.040

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  17 in total

1.  Role of the xenobiotic receptor in inflammatory bowel disease.

Authors:  Razvan Arsenescu; Violeta Arsenescu; Jian Zhong; Munira Nasser; Razvan Melinte; R W Cameron Dingle; Hollie Swanson; Willem J de Villiers
Journal:  Inflamm Bowel Dis       Date:  2010-09-27       Impact factor: 5.325

Review 2.  RelB: an outlier in leukocyte biology.

Authors:  Patrick Millet; Charles McCall; Barbra Yoza
Journal:  J Leukoc Biol       Date:  2013-08-06       Impact factor: 4.962

Review 3.  Sirtuins, melatonin and circadian rhythms: building a bridge between aging and cancer.

Authors:  Brittney Jung-Hynes; Russel J Reiter; Nihal Ahmad
Journal:  J Pineal Res       Date:  2010-01       Impact factor: 13.007

4.  Aryl hydrocarbon receptor regulates the cholesterol biosynthetic pathway in a dioxin response element-independent manner.

Authors:  Rachel Tanos; Rushang D Patel; Iain A Murray; Philip B Smith; Andrew D Patterson; Gary H Perdew
Journal:  Hepatology       Date:  2012-06       Impact factor: 17.425

5.  Role of the Ah receptor in homeostatic control of fatty acid synthesis in the liver.

Authors:  Rachel Tanos; Iain A Murray; Philip B Smith; Andrew Patterson; Gary H Perdew
Journal:  Toxicol Sci       Date:  2012-06-13       Impact factor: 4.849

Review 6.  Molecular clocks in pharmacology.

Authors:  Erik S Musiek; Garret A Fitzgerald
Journal:  Handb Exp Pharmacol       Date:  2013

7.  Attenuation of myocardial injury in mice with functional deletion of the circadian rhythm gene mPer2.

Authors:  Jitka A I Virag; Jessica L Dries; Peter R Easton; Amy M Friesland; Jon H DeAntonio; Vishnu Chintalgattu; Emily Cozzi; Brian D Lehmann; Jian M Ding; Robert M Lust
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-01-08       Impact factor: 4.733

8.  Genetic polymorphisms in the aryl hydrocarbon receptor-signaling pathway and sleep disturbances in middle-aged women.

Authors:  Ayelet Ziv-Gal; Jodi A Flaws; Megan M Mahoney; Susan R Miller; Howard A Zacur; Lisa Gallicchio
Journal:  Sleep Med       Date:  2013-06-13       Impact factor: 3.492

9.  Responsiveness of a Xenopus laevis cell line to the aryl hydrocarbon receptor ligands 6-formylindolo[3,2-b]carbazole (FICZ) and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).

Authors:  Leo B Laub; Brian D Jones; Wade H Powell
Journal:  Chem Biol Interact       Date:  2010-01-05       Impact factor: 5.192

10.  The aryl hydrocarbon receptor-cytochrome P450 1A1 pathway controls lipid accumulation and enhances the permissiveness for hepatitis C virus assembly.

Authors:  Hirofumi Ohashi; Kazane Nishioka; Syo Nakajima; Sulyi Kim; Ryosuke Suzuki; Hideki Aizaki; Masayoshi Fukasawa; Shinji Kamisuki; Fumio Sugawara; Naoko Ohtani; Masamichi Muramatsu; Takaji Wakita; Koichi Watashi
Journal:  J Biol Chem       Date:  2018-10-31       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.